Associated Papers
ATR&RNASEL germline variants: novel findings in a case of familial cancer.
Biswas S et al.
Molecular Genetics and Genomics : Mgg, 2025
Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma.
Öfverholm I et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2024
Gene Variants of the OAS/RNase L Pathway and Their Association with Severity of Symptoms and Outcome of SARS-CoV-2 Infection.
Perez-Favila A et al.
Journal of Personalized Medicine, 2024
Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children.
Lee D et al.
Science (new York, N.y.), 2023
Genomic characterization of lymphomas in patients with inborn errors of immunity.
Ye X et al.
Blood Advances, 2022
Sequence and Structure-Based Analyses of Human Ankyrin Repeats.
Chakrabarty B et al.
Molecules (basel, Switzerland), 2022
PRIMA-1MET-induced neuroblastoma cell death is modulated by p53 and mycn through glutathione level.
Mlakar V et al.
Journal of Experimental & Clinical Cancer Research : Cr, 2019
Whole Exome Sequencing of HIV-1 long-term non-progressors identifies rare variants in genes encoding innate immune sensors and signaling molecules.
Nissen SK et al.
Scientific Reports, 2018
Systematic evaluation of underlying defects in DNA repair as an approach to case-only assessment of familial prostate cancer.
Nicolas E et al.
Oncotarget, 2015
Prognostic role of genetic biomarkers in clinical progression of prostate cancer.
Alvarez-Cubero MJ et al.
Experimental & Molecular Medicine, 2015
Functional and Structural Consequences of Damaging Single Nucleotide Polymorphisms in Human Prostate Cancer Predisposition Gene RNASEL.
Datta A et al.
Biomed Research International, 2015
De novo mutations in moderate or severe intellectual disability.
Hamdan FF et al.
Plos Genetics, 2014
[Hereditary prostate cancer].
Heise M et al.
Postepy Higieny I Medycyny Doswiadczalnej (online), 2014
Genome-wide testing of putative functional exonic variants in relationship with breast and prostate cancer risk in a multiethnic population.
Haiman CA et al.
Plos Genetics, 2013
Positive selection on the gene RNASEL: correlation between patterns of evolution and function.
Jin W et al.
Molecular Biology and Evolution, 2012
Genetic variation in RNASEL and risk for prostate cancer in a population-based case-control study.
Fesinmeyer MD et al.
The Prostate, 2011
Exome sequencing reveals comprehensive genomic alterations across eight cancer cell lines.
Chang H et al.
Plos One, 2011
[RNase L, a crucial mediator of innate immunity and other cell functions].
Bisbal C et al.
Medecine Sciences : M/s, 2008
Germline mutation in RNASEL predicts increased risk of head and neck, uterine cervix and breast cancer.
Madsen BE et al.
Plos One, 2008
RNASEL gene polymorphisms and the risk of prostate cancer: a meta-analysis.
Li H et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2006
[Molecular basis of hereditary hemochromatosis].
Romanowski T et al.
Postepy Higieny I Medycyny Doswiadczalnej (online), 2006
Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene.
Maier C et al.
British Journal of Cancer, 2005
Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2',5'-oligoadenylates.
Xiang Y et al.
Cancer Research, 2003
RNASEL mutations in hereditary prostate cancer.
Chen H et al.
Journal of Medical Genetics, 2003
Implications for RNase L in prostate cancer biology.
Silverman RH
Biochemistry, 2003
Perspective: prostate cancer susceptibility genes.
Simard J et al.
Endocrinology, 2002
Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer.
Rökman A et al.
American Journal of Human Genetics, 2002